{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T11:18:44Z","timestamp":1773314324872,"version":"3.50.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2011,1,13]],"date-time":"2011-01-13T00:00:00Z","timestamp":1294876800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1007\/s12185-010-0745-z","type":"journal-article","created":{"date-parts":[[2011,1,12]],"date-time":"2011-01-12T07:00:53Z","timestamp":1294815653000},"page":"224-227","source":"Crossref","is-referenced-by-count":7,"title":["Primary plasma cell leukemia followed by testicular plasmacytoma"],"prefix":"10.1007","volume":"93","author":[{"given":"Caterina Giovanna","family":"Valentini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Bozzoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luana","family":"Fianchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Teresa","family":"Voso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianluigi","family":"Di Paolantonio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianna","family":"Criscuolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Leone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi Maria","family":"Larocca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Livio","family":"Pagano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,1,13]]},"reference":[{"key":"745_CR1","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/archinte.133.5.813","volume":"133","author":"RA Kyle","year":"1974","unstructured":"Kyle RA, Maldonado JE, Bayrd ED. Plasma cell leukemia. Report on 17 cases. Arch Intern Med. 1974;133:813.","journal-title":"Arch Intern Med"},{"key":"745_CR2","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1046\/j.1365-2141.2003.04355.x","volume":"121","author":"International Myeloma Working Group","year":"2003","unstructured":"International Myeloma Working Group. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br J Haematol. 2003;121:749\u201357.","journal-title":"Br J Haematol"},{"key":"745_CR3","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s12185-009-0288-3","volume":"89","author":"VH Jimenez-Zepeda","year":"2009","unstructured":"Jimenez-Zepeda VH, Dominguez-Martinez VJ. Plasma cell leukemia: a highly aggressive monoclonal gammopathy with a very poor prognosis. Int J Hematol. 2009;89:259\u201368.","journal-title":"Int J Hematol"},{"issue":"2","key":"745_CR4","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0145-2126(00)00102-8","volume":"25","author":"R Costello","year":"2001","unstructured":"Costello R, Sainty D, Bouabdallah R, Fermand JP, Delmer A, Divin\u00e9 M, et al. Primary plasma cell leukemia: a report of 18 cases. Leuk Res. 2001;25(2):103\u20137.","journal-title":"Leuk Res"},{"issue":"6","key":"745_CR5","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/0002-9343(87)90942-9","volume":"83","author":"P Noel","year":"1987","unstructured":"Noel P, Kyle RA. Plasma cell leukemia: an evaluation of response to therapy. Am J Med. 1987;83(6):1062\u20138.","journal-title":"Am J Med"},{"issue":"1","key":"745_CR6","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1023\/A:1014429625266","volume":"33","author":"AF Rose De","year":"2002","unstructured":"De Rose AF, Giglio M, Naselli A, Truini M, Carmignani G. Case report: testicular secondary localization of a multiple myeloma. Int Urol Nephrol. 2002;33(1):101\u20132.","journal-title":"Int Urol Nephrol"},{"issue":"1","key":"745_CR7","first-page":"99","volume":"60","author":"M Alvarez-M\u00fagica","year":"2007","unstructured":"Alvarez-M\u00fagica M, Jal\u00f3n Monz\u00f3n A, Bulnes V\u00e1zquez V, Aguilar Andrea C, Fern\u00e1ndez G\u00f3mez JM, Gonz\u00e1lez Alvarez RC, et al. Secondary testicular plasmocytoma. Arch Esp Urol. 2007;60(1):99\u2013102.","journal-title":"Arch Esp Urol"},{"issue":"1","key":"745_CR8","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/(SICI)1096-8652(199801)57:1<51::AID-AJH9>3.0.CO;2-0","volume":"57","author":"N Turhal","year":"1998","unstructured":"Turhal N, Henehan MD, Kaplan KL. Multiple myeloma: a patient with unusual features including intracranial and meningeal involvement, testicular involvement, organomegaly, and plasma cell leukemia. Am J Hematol. 1998;57(1):51\u20136.","journal-title":"Am J Hematol"},{"issue":"4","key":"745_CR9","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1365-2230.2005.01788.x","volume":"30","author":"DT Alexandrescu","year":"2005","unstructured":"Alexandrescu DT, Koulova L, Wiernik PH. Unusual cutaneous involvement during plasma cell leukaemia phase in a multiple myeloma patient after treatment with thalidomide: a case report and review of the literature. Clin Exp Dermatol. 2005;30(4):391\u20134.","journal-title":"Clin Exp Dermatol"},{"issue":"2","key":"745_CR10","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1600-0609.1980.tb02356.x","volume":"24","author":"UH Lewinski","year":"1980","unstructured":"Lewinski UH, Klein B, Gafter U, Djaldetti M. Acute plasma cell leukaemia followed by extramedullary plasmacytoma. Scand J Haematol. 1980;24(2):131\u20136.","journal-title":"Scand J Haematol"},{"key":"745_CR11","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1038\/sj.leu.2401211","volume":"12","author":"C Pellat-Deceunynck","year":"1998","unstructured":"Pellat-Deceunynck C, Barill\u00e9 S, Jego G, Puthier D, Robillard N, Pineau D, et al. The absence of CD56 (NCAM) on malignant plasma cells is a hallmark of plasma cell leukemia and a special subset of multiple myeloma. Leukemia. 1998;12:1977\u201382.","journal-title":"Leukemia"},{"issue":"749","key":"745_CR12","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1136\/pgmj.64.749.232","volume":"64","author":"JD Walker","year":"1988","unstructured":"Walker JD, Kaczmarski RS. Survival of twenty-two months in a patient with primary plasma cell leukaemia treated with melphalan and prednisolone. Postgrad Med J. 1988;64(749):232\u20135.","journal-title":"Postgrad Med J"},{"issue":"4","key":"745_CR13","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1080\/10428190290017060","volume":"43","author":"J Wellwood","year":"2002","unstructured":"Wellwood J, Taylor K, Wright S, Bentley M, Hill G, Phan H, et al. Relapsed plasma cell leukaemia presenting with aggressive extramedullary plasmacytomas in the meninges and testis\u2014a missed opportunity for induction CNS prophylaxis. Leuk Lymphoma. 2002;43(4):893\u20136.","journal-title":"Leuk Lymphoma"},{"issue":"8","key":"745_CR14","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1080\/10428190500520954","volume":"47","author":"DP Finnegan","year":"2006","unstructured":"Finnegan DP, Kettle P, Drake M, Matthews C, Alexander HD, Popat R, et al. Bortezomib is effective in primary plasma cell leukemia. Leuk Lymphoma. 2006;47(8):1670\u20133.","journal-title":"Leuk Lymphoma"},{"key":"745_CR15","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1080\/02841860600897975","volume":"46","author":"S Capalbo","year":"2007","unstructured":"Capalbo S, Chiefa A, Delia M, Diomede D, Liso V. Effective combination therapy of bortezomib and dexamethasone for a plasma cell leukemia patient with multiple osteolytic lesions and extramedullary involvement. Acta Oncol. 2007;46:262\u20134.","journal-title":"Acta Oncol"},{"issue":"10","key":"745_CR16","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1080\/10428190802290660","volume":"49","author":"C Al-Nawakil","year":"2008","unstructured":"Al-Nawakil C, Tamburini J, Bardet V, Chapuis N, Bourry E, Roux C, et al. Bortezomib, doxorubicin and dexamethasone association is an effective option for plasma cell leukemia induction therapy. Leuk Lymphoma. 2008;49(10):2012\u20134.","journal-title":"Leuk Lymphoma"},{"issue":"11","key":"745_CR17","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1002\/cncr.22700","volume":"109","author":"P Musto","year":"2007","unstructured":"Musto P, Rossini F, Gay F, Pitini V, Guglielmelli T, D\u2019Arena G, et al. Efficacy and safety of bortezomib in patients with plasma cell leukemia. Cancer. 2007;109(11):2285\u201390.","journal-title":"Cancer"},{"issue":"4","key":"745_CR18","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1365-2141.2010.08144.x","volume":"149","author":"AV Singh","year":"2010","unstructured":"Singh AV, Palladino MA, Lloyd GK, Potts BC, Chauhan D, Anderson KC. Pharmacodynamic and efficacy studies of the novel proteasome inhibitor NPI-0052 (marizomib) in a human plasmacytoma xenograft murine model. Br J Haematol. 2010;149(4):550\u20139.","journal-title":"Br J Haematol"},{"key":"745_CR19","unstructured":"Bouchard PR, Juedes MJ, Nix D, Read M. Nonclinical discovery and development of bortezomib (PS-341, VELCADER), a proteasome Inhibitor for the treatment of cancer (13-Nov-2004). In: 55th Annual Meeting of the American College of Veterinary Pathologists (ACVP) and 39th Annual Meeting of the American Society of Clinical Pathology (ASVCP), ACVP and ASVCP, editors. 2004."}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-010-0745-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-010-0745-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-010-0745-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T05:01:37Z","timestamp":1559451697000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-010-0745-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,13]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["745"],"URL":"https:\/\/doi.org\/10.1007\/s12185-010-0745-z","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1,13]]}}}